These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24421903)

  • 1. Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
    Hoffmann CJ; Chaisson RE; Martinson NA
    PLoS One; 2014; 9(1):e83750. PubMed ID: 24421903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
    Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
    Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
    J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa.
    Grimwade K; Sturm AW; Nunn AJ; Mbatha D; Zungu D; Gilks CF
    AIDS; 2005 Jan; 19(2):163-8. PubMed ID: 15668541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
    Raizada N; Chauhan LS; Babu BS; Thakur R; Khera A; Wares DF; Sahu S; Bachani D; Rewari BB; Dewan PK
    PLoS One; 2009 Jun; 4(6):e5999. PubMed ID: 19543396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-life time prediction of developing first-line antiretroviral treatment failure and its risk factors among TB and HIV co-infected children in Northwest Ethiopia; multi setting historical follow-up study.
    Chanie ES; Muche AA; Gobeza MB; Alemu EM; Addis WD; Azanaw MM; Gebremariam AD; Tesfa D; Engidaw MT; Atikilit G; AbebawTiruneh S; Arage G
    BMC Pediatr; 2022 Mar; 22(1):114. PubMed ID: 35241036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa.
    Pemba L; Charalambous S; von Gottberg A; Magadla B; Moloi V; Seabi O; Wasas A; Klugman KP; Chaisson RE; Fielding K; Churchyard GJ; Grant AD
    J Infect; 2008 Mar; 56(3):171-8. PubMed ID: 18262281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Chinji C; Gomani P; Arendt V; Hargreaves NJ; Salaniponi FM; Harries AD
    AIDS; 2003 May; 17(7):1053-61. PubMed ID: 12700456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
    Tanue EA; Nsagha DS; Njamen TN; Assob NJC
    PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.
    Harries AD; Zachariah R; Chimzizi R; Salaniponi F; Gausi F; Kanyerere H; Schouten EJ; Jahn A; Makombe SD; Chimbwandira FM; Mpunga J
    BMC Public Health; 2011 Jul; 11():593. PubMed ID: 21794154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.
    Eholié SP; Ello FN; Coffie PA; Héma A; Minta DK; Sawadogo A
    Trop Med Int Health; 2017 Sep; 22(9):1186-1195. PubMed ID: 28653454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in incidences of tuberculosis in subgroups of South African gold miners.
    Kleinschmidt I; Churchyard G
    Occup Environ Med; 1997 Sep; 54(9):636-41. PubMed ID: 9423575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
    Hoffmann CJ; Fielding KL; Charalambous S; Innes C; Chaisson RE; Grant AD; Churchyard GJ
    AIDS; 2010 Jul; 24(11):1709-16. PubMed ID: 20495439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.